| 11546 | Humans |
| 6706 | Female |
| 4507 | Male |
| 4157 | Middle Aged |
| 4140 | Adult |
| 2782 | Aged |
| 2755 | Lymphedema (etiology) |
| 2531 | Animals |
| 2225 | Lymphedema |
| 1563 | Adolescent |
| 1365 | Lymphedema (therapy) |
| 1233 | Child |
| 1225 | Lymphedema (diagnosis) |
| 1150 | Lymphedema (surgery) |
| 1082 | Human |
| 1052 | Breast Neoplasms (surgery) |
| 953 | Lymphedema (pathology) |
| 911 | Lymphedema (complications) |
| 868 | Aged, 80 and over |
| 851 | Treatment Outcome |
| 809 | Leg |
| 801 | Elephantiasis, Filarial (epidemiology) |
| 777 | Lymphedema (diagnostic imaging) |
| 690 | Arm |
| 681 | Child, Preschool |
| 666 | Follow-Up Studies |
| 653 | Lymphedema (physiopathology) |
| 630 | Lymphography |
| 626 | Treatment |
| 615 | Diagnosis, Differential |
| 581 | Elephantiasis, Filarial (prevention & control) |
| 563 | Elephantiasis, Filarial (drug therapy) |
| 548 | Chronic Disease |
| 521 | Elephantiasis, Filarial (parasitology) |
| 507 | Retrospective Studies |
| 504 | Time Factors |
| 495 | Infant |
| 488 | Risk Factors |
| 484 | Young Adult |
| 470 | Breast Neoplasms (complications) |
| 460 | Elephantiasis, Filarial (immunology) |
| 455 | Lymph Node Excision (adverse effects) |
| 443 | Prevalence |
| 423 | Mastectomy (adverse effects) |
| 421 | Lymphedema (prevention & control) |
| 414 | Syndrome |
| 412 | Quality of Life |
| 409 | Breast Neoplasms (pathology) |
| 398 | Mastectomy |
| 382 | Lymphatic Metastasis |
| 380 | Prognosis |
| 377 | Lymphedema (genetics) |
| 376 | Lymphedema (epidemiology) |
| 360 | Lymph Node Excision |
| 355 | Axilla |
| 351 | Elephantiasis |
| 350 | Breast Neoplasms (therapy) |
| 345 | Wuchereria bancrofti |
| 341 | Prospective Studies |
| 338 | Postoperative Complications |
| 337 | Elephantiasis, Filarial (diagnosis) |
| 323 | Combined Modality Therapy |
| 320 | Surveys and Questionnaires |
| 320 | Complication |
| 319 | Breast Neoplasms (radiotherapy) |
| 311 | Elephantiasis, Filarial (transmission) |
| 308 | Lymphedema (drug therapy) |
| 307 | Diethylcarbamazine (therapeutic use) |
| 302 | Neoplasm Staging |
| 302 | Lymphedema (congenital) |
| 301 | Mice |
| 298 | Lymph Nodes (pathology) |
| 297 | Filaricides (therapeutic use) |
| 296 | Cardiovascular disease |
| 295 | Bandages |
| 294 | Drainage |
| 292 | Wuchereria bancrofti (isolation & purification) |
| 289 | Case study |
| 287 | Lymphatic vessel disease |
| 279 | Wuchereria bancrofti (immunology) |
| 278 | Infant, Newborn |
| 253 | Surgery |
| 248 | Physical Therapy Modalities |
| 247 | Lower limb |
| 245 | Radionuclide Imaging |
| 231 | Skin Neoplasms (pathology) |
| 230 | Lymphatic System (surgery) |
| 221 | Incidence |
| 216 | Cross-Sectional Studies |
| 214 | Mammary gland |
| 209 | Severity of Illness Index |
| 208 | Disease Models, Animal |
| 207 | Lymphoscintigraphy |
| 207 | India (epidemiology) |
| 205 | Lower Extremity |
| 204 | Lymphatic System (pathology) |
| 200 | Methods |
| 200 | Edema |
| 198 | Leg (blood supply) |
| 197 | Antigens, Helminth (immunology) |
| 196 | Lymphedema (psychology) |
| 195 | Malignant tumor |
| 193 | Lymph Node Excision (methods) |
| 192 | Pressure |
| 192 | Lymphatic System (physiopathology) |
| 181 | Skin (pathology) |
| 181 | Postoperative Complications (etiology) |
| 179 | Biopsy |
| 178 | Age Factors |
| 177 | Sensitivity and Specificity |
| 177 | Radiotherapy (adverse effects) |
| 176 | Recurrence |
| 176 | Dogs |
| 172 | Elephantiasis (etiology) |
| 171 | Lymphedema (rehabilitation) |
| 170 | Tomography, X-Ray Computed |
| 169 | Veins (surgery) |
| 169 | Lymphatic System (physiology) |
| 168 | Edema (etiology) |
| 166 | Lymph Nodes (surgery) |
| 165 | Upper limb |
| 165 | Microsurgery (methods) |
| 164 | Lymphedema (nursing) |
| 164 | Elephantiasis, Filarial (pathology) |
| 164 | Diagnosis |
| 163 | Lymphatic Vessels (surgery) |
| 161 | Diethylcarbamazine (administration & dosage) |
| 160 | Elephantiasis, Filarial (blood) |
| 160 | Breast cancer |
| 157 | Elephantiasis, Filarial (complications) |
| 152 | Magnetic Resonance Imaging |
| 151 | Radiography |
| 150 | Reproducibility of Results |
| 149 | India |
| 148 | Rats |
| 148 | Filaricides (administration & dosage) |
| 145 | Lymphography (methods) |
| 145 | Brugia (immunology) |
| 144 | Arm (pathology) |
| 142 | Extremities |
| 142 | Disease |
| 142 | Antigens, Helminth (blood) |
| 141 | Lymph Nodes (diagnostic imaging) |
| 140 | Enzyme-Linked Immunosorbent Assay |
| 138 | Ivermectin (therapeutic use) |
| 138 | Antibodies, Helminth (blood) |
| 137 | Ultrasonography |
| 137 | Skin Transplantation |
| 137 | Pregnancy |
| 137 | Lymphedema (metabolism) |
| 136 | Massage |
| 134 | Case-Control Studies |
| 133 | Microsurgery |
| 132 | Phenotype |
| 131 | Lymph (physiology) |
| 131 | Leg (surgery) |
| 130 | Technique |
| 130 | Pedigree |
| 130 | Lymphatic Vessels (pathology) |
| 128 | Neoplasms (complications) |
| 126 | Surgical Flaps |
| 126 | Sentinel Lymph Node Biopsy |
| 126 | Exercise Therapy |
| 126 | Elephantiasis (pathology) |
| 124 | Scrotum |
| 124 | Microfilariae (isolation & purification) |
| 124 | Lymphatic system |
| 123 | Skin |
| 123 | Leg (pathology) |
| 122 | Chronic |
| 121 | Drug Therapy, Combination |
| 119 | Brugia malayi (immunology) |
| 118 | Limb |
| 118 | Insect Vectors (parasitology) |
| 118 | Hemangiosarcoma (pathology) |
| 118 | Albendazole (therapeutic use) |
| 117 | Cohort Studies |
| 116 | Radiotherapy |
| 115 | Phlebography |
| 115 | Breast Neoplasms (psychology) |
| 114 | Lymphedema (classification) |
| 114 | Lymph Nodes (transplantation) |
| 114 | Dermatology |
| 109 | Patient Education as Topic |
| 109 | Filariasis (epidemiology) |
| 109 | Endemic Diseases |
| 109 | Elephantiasis (diagnosis) |
| 108 | Pilot Projects |
| 108 | Immunohistochemistry |
| 108 | Edema (diagnosis) |
| 107 | Review |
| 107 | Postoperative Complications (prevention & control) |
| 106 | Stockings, Compression |
| 106 | Risk Assessment |
| 106 | Postoperative Complications (epidemiology) |
| 106 | Drainage (methods) |
| 106 | Anastomosis, Surgical |
| 105 | Predictive Value of Tests |
| 104 | Transplantation, Autologous |
| 104 | Brugia |
| 103 | Lymphedema (immunology) |
| 102 | Survivors |
| 102 | Lymphatic |
| 102 | Culex (parasitology) |
| 101 | Mutation |
| 101 | Elephantiasis (surgery) |
| 101 | Breast Neoplasms (rehabilitation) |
| 101 | Anti-Bacterial Agents (therapeutic use) |
| 101 | Anastomosis, Surgical (methods) |
| 100 | Sex Factors |
| 100 | Filariasis (immunology) |
| 98 | Health Knowledge, Attitudes, Practice |
| 98 | Elephantiasis (epidemiology) |
| 98 | Anthelmintics (therapeutic use) |
| 97 | Carcinoma, Squamous Cell (surgery) |
| 96 | Wuchereria bancrofti (drug effects) |
| 96 | Survival Rate |
| 96 | Microfilariae (immunology) |
| 94 | Postoperative Complications (therapy) |
| 94 | Drug Administration Schedule |
| 94 | Compression Bandages |
| 93 | Sentinel Lymph Node Biopsy (adverse effects) |
| 92 | Leg (diagnostic imaging) |
| 91 | Lymphangiosarcoma (etiology) |
| 90 | Age Distribution |
| 89 | Molecular Sequence Data |
| 88 | Skin disease |
| 88 | Skin Neoplasms (surgery) |
| 88 | Lymphangiosarcoma (pathology) |
| 88 | Immunoglobulin G (blood) |
| 87 | Uterine Cervical Neoplasms (surgery) |
| 87 | Neoplasm Recurrence, Local |
| 87 | Insect Vectors |
| 86 | Postoperative Care |
| 86 | Microfilariae |
| 86 | Lymphatic Vessels (diagnostic imaging) |
| 85 | Melanoma (surgery) |
| 85 | Exploration |
| 85 | Breast Neoplasms (drug therapy) |
| 84 | Obesity (complications) |
| 84 | Ivermectin (administration & dosage) |
| 84 | Acute Disease |
| 83 | Pain (etiology) |
| 83 | Genital Diseases, Male (surgery) |
| 83 | Double-Blind Method |
| 83 | Chyle |
| 82 | Postoperative Complications (surgery) |
| 81 | Skin Neoplasms (etiology) |
| 81 | Scintigraphy |
| 81 | Longitudinal Studies |
| 81 | Edema (therapy) |
| 81 | Arm (surgery) |
| 81 | Antigens, Helminth (analysis) |
| 80 | Upper Extremity |
| 80 | Scrotum (surgery) |
| 80 | Global Health |
| 80 | Gerbillinae |
| 79 | Skin Neoplasms (complications) |
| 79 | Randomized Controlled Trials as Topic |
| 79 | Lymphatic System (anatomy & histology) |
| 79 | Body Mass Index |
| 79 | Albendazole (administration & dosage) |
| 78 | Reconstructive Surgical Procedures (methods) |
| 78 | Postoperative Complications (diagnosis) |
| 78 | Morbidity |
| 78 | Breast Neoplasms (mortality) |
| 77 | Lymphangiogenesis (physiology) |
| 77 | Cells, Cultured |
| 77 | Axilla (surgery) |
| 76 | Rural Population |
| 76 | Electric Impedance |
| 75 | Wound Healing |
| 75 | Radiotherapy, Adjuvant (adverse effects) |
| 75 | Mastectomy (methods) |
| 75 | Disease Progression |
| 74 | Vulvar Neoplasms (surgery) |
| 74 | Neoplasm Metastasis |
| 74 | Endemic Diseases (prevention & control) |
| 73 | Range of Motion, Articular |
| 73 | Hemangiosarcoma (etiology) |
| 73 | Elephantiasis (therapy) |
| 72 | Radiotherapy, Adjuvant |
| 72 | Lymphatic System |
| 72 | Lymph |
| 72 | Feasibility Studies |
| 71 | Survival Analysis |
| 71 | Socioeconomic Factors |
| 71 | Mastectomy, Segmental |
| 71 | Fatal Outcome |
| 71 | Adaptation, Psychological |
| 70 | Lymphadenectomy |
| 69 | Models, Biological |
| 69 | Mice, Inbred C57BL |
| 69 | Lymphangiogenesis |
| 69 | Kinesitherapy |
| 69 | Elephantiasis, Filarial (therapy) |
| 69 | Culicidae (parasitology) |
| 69 | Coloring Agents |
| 69 | Breast Neoplasms (physiopathology) |
| 68 | Lymphatic System (abnormalities) |
| 68 | Contrast Media |
| 68 | Breast Neoplasms (diagnosis) |
| 67 | Wuchereria bancrofti (genetics) |
| 67 | Tumor |
| 67 | Technetium |
| 67 | Lower Extremity (pathology) |
| 67 | Hand |
| 67 | Filariasis (complications) |
| 67 | Eyelashes (abnormalities) |
| 66 | Skin Neoplasms (diagnosis) |
| 66 | Radiotherapy Dosage |
| 66 | Disease-Free Survival |
| 66 | Chemotherapy |
| 66 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 66 | Analysis of Variance |
| 65 | Rabbits |
| 65 | Penile Diseases (surgery) |
| 65 | Patient Compliance |
| 65 | Obesity, Morbid (complications) |
| 65 | Lymphedema (chemically induced) |
| 65 | Exercise |
| 65 | Association |
| 64 | Rural Health |
| 64 | Lymphatic Vessels (physiology) |
| 64 | Lymphatic Vessels (metabolism) |
| 64 | Congenital |
| 64 | Amino Acid Sequence |
| 64 | Activities of Daily Living |
| 63 | Radiopharmaceuticals |
| 63 | Postoperative |
| 63 | Groin |
| 63 | Carcinoma |
| 62 | Wuchereria bancrofti (growth & development) |
| 62 | United Kingdom |
| 62 | Indocyanine Green |
| 62 | Filariasis (drug therapy) |
| 62 | Chemotherapy, Adjuvant |
| 62 | Arm (physiopathology) |
| 62 | Amputation |
| 61 | Vulvar Neoplasms (pathology) |
| 61 | Lymph node |
| 61 | Logistic Models |
| 61 | Filariasis (diagnosis) |
| 61 | Ethiopia |
| 61 | Equipment Design |
| 61 | Clothing |
| 60 | Venous Insufficiency (therapy) |
| 60 | Medical Records |
| 60 | Coumarins (therapeutic use) |
| 60 | Breast Neoplasms (diagnostic imaging) |
| 59 | Vascular Endothelial Growth Factor Receptor-3 (genetics) |
| 59 | Sentinel Lymph Node Biopsy (methods) |
| 59 | Self Care |
| 59 | Mice, Inbred BALB C |
| 59 | Filariasis (parasitology) |
| 59 | Diethylcarbamazine (adverse effects) |
| 58 | Venous Insufficiency (complications) |
| 58 | Penis |
| 58 | Lymphatic Diseases (diagnostic imaging) |
| 58 | Lymphangiosarcoma |
| 58 | Antibodies, Helminth (immunology) |
| 57 | United States |
| 57 | Survivors (psychology) |
| 57 | Practice Guidelines as Topic |
| 57 | Microscopy, Electron |
| 57 | Microfilariae (drug effects) |
| 57 | Lymphatic Vessels (physiopathology) |
| 57 | Breast |
| 57 | Arm (blood supply) |
| 56 | Sex Distribution |
| 56 | Medicine |
| 56 | Filariasis |
| 56 | Edema (physiopathology) |
| 56 | Base Sequence |
| 55 | Epidemiology |
| 55 | Anopheles (parasitology) |
| 54 | World Health Organization |
| 54 | Physical Therapy Modalities (methods) |
| 54 | Lymphocyte Activation |
| 54 | Hemangiosarcoma (diagnosis) |
| 54 | Comorbidity |
| 54 | Arm (diagnostic imaging) |
| 53 | Tropical medicine |
| 53 | Population Surveillance |
| 53 | Pathology |
| 53 | Nursing Assessment |
| 53 | Elephantiasis (complications) |
| 53 | Carcinoma, Squamous Cell (pathology) |
| 53 | Angiography |
| 52 | Uterine Cervical Neoplasms (pathology) |
| 52 | Upper Extremity (pathology) |
| 52 | Treatment efficiency |
| 52 | Scrotum (pathology) |
| 52 | Pleural Effusion (complications) |
| 52 | Penis (surgery) |
| 52 | Palliative Care |
| 52 | Multivariate Analysis |
| 52 | Magnetic Resonance Imaging (methods) |
| 52 | Lymphangiosarcoma (diagnosis) |
| 52 | Hindlimb |
| 51 | Quality of life |
| 51 | Prevention |
| 51 | Nail Diseases (complications) |
| 51 | Melanoma (pathology) |
| 51 | Exercise Therapy (methods) |
| 51 | Attitude to Health |
| 50 | Wuchereria bancrofti (physiology) |
| 50 | Risk factor |
| 50 | Pathophysiology |
| 50 | Mosquito Control (methods) |
| 50 | Lymphedema (blood) |
| 50 | Lymphatic filariasis |
| 50 | Lymphatic Diseases (diagnosis) |
| 50 | Inguinal Canal |
| 50 | Carcinoma (surgery) |
| 50 | Breast Neoplasms (epidemiology) |
| 50 | Angiosarcoma |
| 49 | Symptomatology |
| 49 | Neoplasms (therapy) |
| 49 | Leg Ulcer (etiology) |
| 49 | Fibrosis |
| 49 | Clinical Trials as Topic |
| 49 | Abnormalities, Multiple (genetics) |
| 48 | Venous Insufficiency (diagnosis) |
| 48 | Social Support |
| 48 | Onchocerciasis (drug therapy) |
| 48 | Mastectomy, Radical |
| 48 | Lymph Nodes (blood supply) |
| 48 | Lipectomy |
| 48 | Elephantiasis, Filarial (physiopathology) |
| 48 | Elephantiasis, Filarial (diagnostic imaging) |
| 48 | Anthelmintics (administration & dosage) |
| 47 | Physiotherapy |
| 47 | Mastectomy, Radical (adverse effects) |
| 47 | Genital Neoplasms, Female (surgery) |
| 47 | Elephantiasis, Filarial (economics) |
| 47 | Developing Countries |
| 47 | Cellulitis (etiology) |
| 46 | T-Lymphocytes (immunology) |
| 46 | Surgical Flaps (blood supply) |
| 46 | Regression Analysis |
| 46 | Preoperative Care |
| 46 | Onchocerciasis (epidemiology) |
| 46 | Lymphatic Metastasis (pathology) |
| 46 | History, 20th Century |
| 46 | Genotype |
| 46 | Brugia malayi |
| 45 | Technetium Tc 99m Sulfur Colloid |
| 45 | Skin (blood supply) |
| 45 | Program Evaluation |
| 45 | Penile Diseases (etiology) |
| 45 | Onchocerciasis (prevention & control) |
| 45 | Health Surveys |
| 45 | Genetic Predisposition to Disease |
| 45 | Forkhead Transcription Factors (genetics) |
| 45 | Foot |
| 45 | Evidence-Based Medicine |
| 45 | Compression |
| 45 | Carcinoma, Ductal, Breast (surgery) |
| 44 | Lymphangioma (pathology) |
| 44 | Family study |
| 44 | Erysipelas (complications) |
| 44 | Endometrial Neoplasms (surgery) |
| 44 | Elephantiasis, Filarial (psychology) |
| 44 | Edema (pathology) |
| 44 | Edema (diagnostic imaging) |
| 44 | Comparative study |
| 44 | Brugia malayi (isolation & purification) |
| 44 | Algorithms |
| 43 | Uterine Cervical Neoplasms (radiotherapy) |
| 43 | Thrombophlebitis (complications) |
| 43 | Technetium Tc 99m Aggregated Albumin |
| 43 | Signal Transduction |
| 43 | Sarcoma |
| 43 | Reoperation |
| 43 | Postoperative Period |
| 43 | Melanoma (secondary) |
| 43 | Lymphatic Diseases (complications) |
| 43 | Lymphangiogenesis (genetics) |
| 43 | Filariasis (prevention & control) |
| 43 | Enzyme-Linked Immunosorbent Assay (methods) |
| 43 | Cancerology |
| 43 | Biopsy, Needle |
| 43 | Antibodies, Helminth (analysis) |
| 42 | Venous Insufficiency (physiopathology) |
| 42 | Thigh |
| 42 | Quality of Life (psychology) |
| 42 | Patient Care Team |
| 42 | Neoplasm Invasiveness |
| 42 | Lymphatic Vessels (embryology) |
| 42 | Lymphatic Metastasis (diagnosis) |
| 42 | Lymphangiectasis |
| 42 | Immunity, Cellular |
| 42 | Filaricides (pharmacology) |
| 42 | Ethiopia (epidemiology) |
| 42 | Endothelial Cells (metabolism) |
| 42 | Dose-Response Relationship, Drug |
| 42 | Brugia (isolation & purification) |
| 42 | Brazil |
| 42 | Antineoplastic Agents (adverse effects) |
